logo
logo

Enveda secures $55 million in Series B extension to integrate ancient remedies with AI for drug discovery.

Enveda secures $55 million in Series B extension to integrate ancient remedies with AI for drug discovery.

06/14/24, 2:38 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgboulder
Money raised
$55 million
Round Type
series b
Investors
Jazz Venture Partners, Level Ventures, Fpv, True Ventures, Kinnevik, Lingotto Investment Fund, Premji Invest, The Nature Conservancy, Microsoft
Enveda announced a $55 million Series B extension from new investors to integrate ancient remedies with AI to discover new drugs. The latest funding round brings Enveda’s total capital to $230 million and involves contributions from both new and existing investors.

Company Info

Company
Enveda Biosciences
Location
1880 s flatiron ct. ste. k
boulder, colorado, united states
Additional Info
Enveda Biosciences is a biotechnology company building the first high-resolution chemical map of the natural world to tackle the toughest problems in drug discovery. Enveda’s platform is the world’s most advanced drug discovery search engine for dark chemical space, building on years of cutting-edge advancements at the intersection of metabolomics and machine learning. Complementing its breakthrough technology, Enveda’s team includes seasoned drug hunters with decades of experience in the pharmaceutical industry working alongside world-leading data scientists. For more information on Enveda, visit envedabio.com.

Related People